Protagenic Therapeutics
Stock Forecast, Prediction & Price Target
Protagenic Therapeutics Financial Estimates
Protagenic Therapeutics Revenue Estimates
Protagenic Therapeutics EBITDA Estimates
Protagenic Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | |||
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | |||
Net Income
% change YoY
| $-4.98M N/A | $-3.60M 27.77% | $-5.00M -38.84% | Avg: $-10.94M Low: $-10.94M High: $-10.94M avg. -118.94% | |||
EBITDA
% change YoY
| $-4.10M N/A | $-3.37M 17.90% | $-4.49M -33.41% | Avg: $0 Low: $0 High: $0 avg. 100% | |||
EPS
% change YoY
| -$1.35 N/A | -$0.83 38.51% | -$1.15 -38.55% | Avg: -$2.52 Low: -$2.52 High: -$2.52 avg. -119.13% | |||
Operating Expenses
% change YoY
| $4.14M N/A | $3.55M -14.07% | $4.52M 27.24% | Avg: $0 Low: $0 High: $0 avg. -100% | |||
FAQ
What is Protagenic Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -118.94% in 2025-2025.
We have gathered data from N/A analysts. Their low estimate is -10.94M, average is -10.94M and high is -10.94M.
What is Protagenic Therapeutics stock revenue growth forecast?
We have gathered data from N/A analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Protagenic Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -119.13% in 2025-2025.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$2.52, average is -$2.52 and high is $-2.52.